Published in Virulence on April 05, 2013
Microbial persistence and the road to drug resistance. Cell Host Microbe (2013) 1.37
A conformational landscape for alginate secretion across the outer membrane of Pseudomonas aeruginosa. Acta Crystallogr D Biol Crystallogr (2014) 0.93
Colonization of cecum is important for development of persistent infection by Yersinia pseudotuberculosis. Infect Immun (2014) 0.89
Nitrogen gas flushing can be bactericidal: the temperature-dependent destiny of Bacillus weihenstephanensis KBAB4 under a pure N2 atmosphere. Front Microbiol (2014) 0.83
RNA Futile Cycling in Model Persisters Derived from MazF Accumulation. MBio (2015) 0.83
Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts. Microb Biotechnol (2016) 0.81
Probiotics to counteract biofilm-associated infections: promising and conflicting data. Int J Oral Sci (2014) 0.81
Stationary-Phase Persisters to Ofloxacin Sustain DNA Damage and Require Repair Systems Only during Recovery. MBio (2015) 0.80
Cigarette smoke condensate increases C. albicans adhesion, growth, biofilm formation, and EAP1, HWP1 and SAP2 gene expression. BMC Microbiol (2014) 0.79
Distribution and Inhibition of Liposomes on Staphylococcus aureus and Pseudomonas aeruginosa Biofilm. PLoS One (2015) 0.78
Bacterial persistence is an active σS stress response to metabolic flux limitation. Mol Syst Biol (2016) 0.78
In Vitro Emergence of High Persistence upon Periodic Aminoglycoside Challenge in the ESKAPE Pathogens. Antimicrob Agents Chemother (2016) 0.77
Biofilms and Wounds: An Overview of the Evidence. Adv Wound Care (New Rochelle) (2015) 0.77
Fumarate-Mediated Persistence of Escherichia coli against Antibiotics. Antimicrob Agents Chemother (2016) 0.76
Persistent bacterial infections and persister cells. Nat Rev Microbiol (2017) 0.75
Microdissection approaches in tuberculosis research. J Med Primatol (2014) 0.75
Antibacterial and Antibiofilm Activity of Methanolic Plant Extracts against Nosocomial Microorganisms. Evid Based Complement Alternat Med (2016) 0.75
Kinetic and structural characterization for cofactor preference of succinic semialdehyde dehydrogenase from Streptococcus pyogenes. Mol Cells (2014) 0.75
DNA-based culture-independent analysis detects the presence of group a streptococcus in throat samples from healthy adults in Japan. BMC Microbiol (2016) 0.75
Phenotypic Modifications in Staphylococcus aureus Cells Exposed to High Concentrations of Vancomycin and Teicoplanin. Front Microbiol (2016) 0.75
A Highly Potent Class of Halogenated Phenazine Antibacterial and Biofilm-Eradicating Agents Accessed Through a Modular Wohl-Aue Synthesis. Sci Rep (2017) 0.75
Modeling the kinetics of the permeation of antibacterial agents into growing bacteria and its interplay with efflux. Antimicrob Agents Chemother (2017) 0.75
Metabolomic profile and nucleoside composition of Cordyceps nidus sp. nov. (Cordycipitaceae): A new source of active compounds. PLoS One (2017) 0.75
Bacterial biofilms: a common cause of persistent infections. Science (1999) 40.82
Bacterial persistence as a phenotypic switch. Science (2004) 15.80
A common mechanism of cellular death induced by bactericidal antibiotics. Cell (2007) 12.92
Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment. J Exp Med (2003) 10.67
Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature (2000) 10.32
Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet (1991) 9.51
Lung infections associated with cystic fibrosis. Clin Microbiol Rev (2002) 9.20
Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol (2002) 8.90
Persister cells, dormancy and infectious disease. Nat Rev Microbiol (2006) 8.35
Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol (2003) 7.29
Cellular defenses against superoxide and hydrogen peroxide. Annu Rev Biochem (2008) 5.94
Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol (2004) 5.82
Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol (2006) 5.73
Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science (2003) 5.50
hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol (1983) 4.59
Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother (2003) 4.59
Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother (2000) 4.41
M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb) (2004) 4.38
SOS response induction by beta-lactams and bacterial defense against antibiotic lethality. Science (2004) 4.20
Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A (2004) 4.12
Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions. Infect Immun (1982) 4.02
Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol Syst Biol (2007) 3.98
Microbial persistence. Yale J Biol Med (1958) 3.80
Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science (2011) 3.66
Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis (1998) 3.61
D-amino acids trigger biofilm disassembly. Science (2010) 3.60
Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med (2007) 3.54
Bacterial persistence by RNA endonucleases. Proc Natl Acad Sci U S A (2011) 3.52
Bacterial charity work leads to population-wide resistance. Nature (2010) 3.50
Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell (2011) 3.42
Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A (2006) 3.36
Dynamic persistence of antibiotic-stressed mycobacteria. Science (2013) 3.34
Global gene expression in Escherichia coli biofilms. Mol Microbiol (2003) 3.33
Non-inherited antibiotic resistance. Nat Rev Microbiol (2006) 3.25
A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol (1997) 3.25
Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat Rev Microbiol (2004) 3.23
Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med (1994) 3.19
Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol (2010) 3.12
Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science (2013) 2.97
Signaling-mediated bacterial persister formation. Nat Chem Biol (2012) 2.96
Cell death from antibiotics without the involvement of reactive oxygen species. Science (2013) 2.95
Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J Infect Dis (1994) 2.91
Molecular mechanisms of HipA-mediated multidrug tolerance and its neutralization by HipB. Science (2009) 2.74
Recurring urinary tract infection: incidence and risk factors. Am J Public Health (1990) 2.62
The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice. Proc Natl Acad Sci U S A (2003) 2.60
Involvement of the relA gene in the autolysis of Escherichia coli induced by inhibitors of peptidoglycan biosynthesis. J Bacteriol (1985) 2.50
Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis. Am J Respir Crit Care Med (2001) 2.46
Staphylococcus aureus as an intracellular pathogen: the role of small colony variants. Trends Microbiol (2009) 2.38
Innate and induced resistance mechanisms of bacterial biofilms. Curr Top Microbiol Immunol (2008) 2.35
Bacterial persistence and toxin-antitoxin loci. Annu Rev Microbiol (2012) 2.28
SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet (2009) 2.28
Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol Microbiol (2004) 2.26
Recurrent urinary tract infection in women. Int J Antimicrob Agents (2001) 2.26
Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob Agents Chemother (1991) 2.26
Pseudomonas aeruginosa rugose small-colony variants have adaptations that likely promote persistence in the cystic fibrosis lung. J Bacteriol (2009) 2.22
Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli. J Exp Med (1966) 2.19
Mycobacterial survival strategies in the phagosome: defence against host stresses. Cell Microbiol (2009) 2.18
Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin Infect Dis (1999) 2.18
Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother (2003) 2.16
Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med (2011) 2.15
Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier's disease. Clin Infect Dis (2001) 2.14
Distribution and excretion of radioactive isoniazid in tuberculous patients. J Am Med Assoc (1953) 2.14
Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol (2010) 2.11
Contribution of oxidative damage to antimicrobial lethality. Antimicrob Agents Chemother (2009) 2.09
Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis (2003) 2.05
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother (2010) 2.05
Biological basis for syphilis. Clin Microbiol Rev (2006) 2.01
Endogenous oxidative stress produces diversity and adaptability in biofilm communities. Proc Natl Acad Sci U S A (2008) 2.00
Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity. Annu Rev Med (2012) 1.96
Diagnosis and management of syphilis. Am Fam Physician (2003) 1.95
ppGpp: magic beyond RNA polymerase. Nat Rev Microbiol (2012) 1.91
Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog (2010) 1.88
Dynamics of intracellular bacterial replication at the single cell level. Proc Natl Acad Sci U S A (2010) 1.83
Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species. J Biol Chem (2010) 1.80
Effects of RelA on key virulence properties of planktonic and biofilm populations of Streptococcus mutans. Infect Immun (2004) 1.79
Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs (2005) 1.78
Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev Anti Infect Ther (2003) 1.77
Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu Rev Microbiol (2010) 1.74
Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals. Proc Natl Acad Sci U S A (2012) 1.74
Mycobacterium tuberculosis and the intimate discourse of a chronic infection. Immunol Rev (2011) 1.72
Medical biofilms. Biotechnol Bioeng (2008) 1.70
Biofilm formation by the small colony variant phenotype of Pseudomonas aeruginosa. Environ Microbiol (2004) 1.64
Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. MBio (2011) 1.64
Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production. Nat Biotechnol (2013) 1.59
Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother (2005) 1.55
The economic impact of infected joint arthroplasty. Orthopedics (1995) 1.52
Chronic and acute infection of the gall bladder by Salmonella Typhi: understanding the carrier state. Nat Rev Microbiol (2010) 1.50
Heterogeneous bacterial persisters and engineering approaches to eliminate them. Curr Opin Microbiol (2011) 1.47
Direct correlation between overproduction of guanosine 3',5'-bispyrophosphate (ppGpp) and penicillin tolerance in Escherichia coli. J Bacteriol (1995) 1.45
The communication factor EDF and the toxin-antitoxin module mazEF determine the mode of action of antibiotics. PLoS Biol (2008) 1.45
Decreased susceptibility to antibiotic killing of a stable small colony variant of Staphylococcus aureus in fluid phase and on fibronectin-coated surfaces. J Antimicrob Chemother (1997) 1.44
Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis (2010) 1.43
Gallstones play a significant role in Salmonella spp. gallbladder colonization and carriage. Proc Natl Acad Sci U S A (2010) 1.42
Hemophagocytic macrophages harbor Salmonella enterica during persistent infection. PLoS Pathog (2007) 1.41
Role of oxidative stress in persister tolerance. Antimicrob Agents Chemother (2012) 1.40
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth. Antimicrob Agents Chemother (2009) 1.38
Thymidine-dependent Staphylococcus aureus small-colony variants are associated with extensive alterations in regulator and virulence gene expression profiles. Infect Immun (2005) 1.35
Mechanism of persistent infection associated with peritoneal implants. J Med Microbiol (1992) 1.33
Staphylococcus aureus small colony variants, electron transport and persistent infections. Int J Antimicrob Agents (2000) 1.31
Reexamining syphilis: an update on epidemiology, clinical manifestations, and management. Ann Pharmacother (2008) 1.30
Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol (2007) 4.83
Genomic epidemiology of the Escherichia coli O104:H4 outbreaks in Europe, 2011. Proc Natl Acad Sci U S A (2012) 3.42
Sensitive, specific polymorphism discovery in bacteria using massively parallel sequencing. Nat Methods (2008) 2.61
Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening. ACS Chem Biol (2012) 1.83
Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals. Proc Natl Acad Sci U S A (2012) 1.74
Virstatin inhibits dimerization of the transcriptional activator ToxT. Proc Natl Acad Sci U S A (2007) 1.42
Pseudomonas aeruginosa infection of zebrafish involves both host and pathogen determinants. Infect Immun (2009) 1.39
RNA signatures allow rapid identification of pathogens and antibiotic susceptibilities. Proc Natl Acad Sci U S A (2012) 1.23
Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32. Proc Natl Acad Sci U S A (2013) 1.11
Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis. Nat Chem Biol (2013) 1.04
Productive steps toward an antimicrobial targeting virulence. Curr Opin Microbiol (2009) 1.02
The sensor kinase KinB regulates virulence in acute Pseudomonas aeruginosa infection. J Bacteriol (2011) 0.94
Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation model. ACS Chem Biol (2013) 0.92
GRP78(BiP) facilitates the cytosolic delivery of anthrax lethal factor (LF) in vivo and functions as an unfoldase in vitro. Mol Microbiol (2011) 0.87
Chemical tools for dissecting bacterial physiology and virulence. Biochemistry (2009) 0.86
Direct detection and drug-resistance profiling of bacteremias using inertial microfluidics. Lab Chip (2015) 0.85
CCT chaperonin complex is required for efficient delivery of anthrax toxin into the cytosol of host cells. Proc Natl Acad Sci U S A (2013) 0.85
The fast track to multidrug resistance. Mol Cell (2010) 0.84
How antibiotics kill bacteria: new models needed? Nat Med (2013) 0.83
Systematics-guided bioprospecting for bioactive microbial natural products. Antonie Van Leeuwenhoek (2011) 0.81
Probing bacterial pathogenesis with genetics, genomics, and chemical biology: past, present, and future approaches. Crit Rev Biochem Mol Biol (2011) 0.80
The two-component sensor KinB acts as a phosphatase to regulate Pseudomonas aeruginosa Virulence. J Bacteriol (2012) 0.80
Synthesis and structure-activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32. Bioorg Med Chem Lett (2013) 0.79
Reply to Guy et al.: Support for a bottleneck in the 2011 Escherichia coli O104:H4 outbreak in Germany. Proc Natl Acad Sci U S A (2012) 0.78
The two-component sensor kinase KinB acts as a non-canonical switch between acute and chronic infection. Virulence (2011) 0.78
Identification of novel host-targeted compounds that protect from anthrax lethal toxin-induced cell death. ACS Chem Biol (2013) 0.77
Targeting multiple biofilm pathways. Chem Biol (2009) 0.76
Resuscitation-promoting factors are required for β-lactam tolerance and the permeability barrier in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2011) 0.76
Toward a systems-level analysis of infection biology: a new method for conducting genetic screens in human cells. Sci Transl Med (2009) 0.75
Continuous and High-throughput Electromechanical Lysis of Bacterial Pathogens using Ion Concentration Polarization. Anal Chem (2017) 0.75